Fresenius Kabi recalls
2 notices naming Fresenius Kabi as the recalling firm, since August 4, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles
Hazard (FDA): Due to Presence of Glass Particles
FDAMedicines
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
Hazard (FDA): Due to a label mix-up
FDAMedicines